The only prior study of EZH2 for thymic carcinoma versus thymoma used tissue microarrays to assess EZH2 in thymic squamous cell carcinomas (n = 27) and B3 thymomas (n = 26) [4]. This evidence concerns the gene EZH2 and thymoma.